drugset / Trial / NCT00002354

A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients

NCT00002354

Completed 540 enrolled Merck Sharp & Dohme LLC
Double-blindTreatment

Summary

The purpose of this study is to see if it is safe and effective to give indinavir sulfate plus stavudine to HIV-infected patients who have already been treated with zidovudine.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject INDINAVIR ANHYDROUS Other / unclassified
Subject Stavudine Other / unclassified